Menu
Back to Journals » OncoTargets and Therapy » Volume 2 » default
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6336)
- Volume 16, 2023 (45)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 2, 2009
Bendamustine in the treatment of non-Hodgkin’s lymphomas
Fredrick Hagemeister, George Manoukian
OncoTargets and Therapy 2009, 2:269-279
Published Date: 4 December 2009
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
Khaldoun Almhanna, Philip A Philip
OncoTargets and Therapy 2009, 2:261-267
Published Date: 13 November 2009
Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
Charu Aggarwal, Hossein Borghaei
OncoTargets and Therapy 2009, 2:251-260
Published Date: 31 August 2009
Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
Francesco Perri, Francesco Longo, Franco Ionna, et al
OncoTargets and Therapy 2009, 2:243-250
Published Date: 31 August 2009
Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma
Michael J Burdick, Roger M Macklis
OncoTargets and Therapy 2009, 2:229-242
Published Date: 19 August 2009
Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia
Kelly M Reilly, David F Kisor
OncoTargets and Therapy 2009, 2:219-228
Published Date: 6 August 2009
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
Luca Toschi, Federico Cappuzzo
OncoTargets and Therapy 2009, 2:209-217
Published Date: 3 August 2009
Update on the rational use of (90)Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
Martina Lehnert, Heinz Ludwig, Niklas Zojer
OncoTargets and Therapy 2009, 2:199-208
Published Date: 31 July 2009
Expanded use of rituximab in the management of non-Hodgkin lymphoma
Dennis A Eichenauer, Andreas Engert, Holger Schulz
OncoTargets and Therapy 2009, 2:189-197
Published Date: 31 July 2009
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
Francesco Di Costanzo, Silvia Gasperoni, Virginia Rotella, Federica Di Costanzo
OncoTargets and Therapy 2009, 2:179-188
Published Date: 7 July 2009
The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib
A Milano, F Perri, F Caponigro
OncoTargets and Therapy 2009, 2:171-178
Published Date: 30 June 2009
Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
Kerry J Williams, A Craig Lockhart
OncoTargets and Therapy 2009, 2:161-170
Published Date: 30 June 2009
Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)
John T Vetto
OncoTargets and Therapy 2009, 2:151-159
Published Date: 25 June 2009
Multiple roles and therapeutic implications of Akt signaling in cancer
Emiliano Calvo, Victoria Bolós, Enrique Grande
OncoTargets and Therapy 2009, 2:135-150
Published Date: 5 June 2009
Targeted therapy in the treatment of malignant gliomas
Rimas V Lukas, Adrienne Boire, M Kelly Nicholas
OncoTargets and Therapy 2009, 2:115-133
Published Date: 13 May 2009
Role of trabectedin in the treatment of soft tissue sarcoma
Alexandre Christinat, Serge Leyvraz
OncoTargets and Therapy 2009, 2:105-113
Published Date: 6 May 2009
The evolving role of zoledronic acid in early breast cancer
Michael Gnant
OncoTargets and Therapy 2009, 2:95-104
Published Date: 26 April 2009
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
Charles Chuah, Junia V Melo
OncoTargets and Therapy 2009, 2:83-94
Published Date: 24 April 2009
First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
Giuseppe Tonini, Alice Calvieri, Bruno Vincenzi, Daniele Santini
OncoTargets and Therapy 2009, 2:73-82
Published Date: 7 April 2009
Targeted treatment of chronic myeloid leukemia: role of imatinib
Ila Tamascar, Jeyanthi Ramanarayanan
OncoTargets and Therapy 2009, 2:63-71
Published Date: 25 March 2009
Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma
Anita Schwandt1, Laura S Wood1, Brian Rini1,2, Robert Dreicer1,2
OncoTargets and Therapy 2009, 2:51-61
Published Date: 16 March 2009
Role of bendamustine in the treatment of chronic lymphocytic leukemia
Saad Jamshed, Bruce D Cheson
OncoTargets and Therapy 2009, 2:43-49
Published Date: 12 March 2009
Targeting cancers in the gastrointestinal tract: role of capecitabine
Muhammad Wasif Saif
OncoTargets and Therapy 2009, 2:29-41
Published Date: 25 March 2009
Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients
Per Pfeiffer, Camilla Qvortrup, Jon K Bjerregaard
OncoTargets and Therapy 2009, 2:17-27
Published Date: 23 December 2008
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab
Ajithkumar Puthillath, Anush Patel, Marwan G Fakih
OncoTargets and Therapy 2009, 2:1-15
Published Date: 27 November 2008